Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines

Background: Recombinant pertussis vaccines inducing long-lasting immune responses could help to control the rise in pertussis. We here report on persisting antibody responses 2 and 3 years after booster vaccination with a new generation recombinant acellular pertussis vaccine. Methods: Participants...

Full description

Bibliographic Details
Main Authors: Punnee Pitisuttithum, Jittima Dhitavat, Chukiat Sirivichayakul, Arom Pitisuthitham, Yupa Sabmee, Pailinrut Chinwangso, Chawanee Kerdsomboon, Librada Fortuna, Jane Spiegel, Mukesh Chauhan, Indrajeet Kumar Poredi, Anita H.J. van den Biggelaar, Wassana Wijagkanalan, Simonetta Viviani, Souad Mansouri, Hong Thai Pham
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:EClinicalMedicine
Subjects:
Pertussis
Acellular
Vaccine
Recombinant
Genetically
Monovalent
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702100256X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702100256X

Similar Items